Trademark: 85058091
Status Date
Monday, December 9, 2013
Filing Date
Wednesday, June 9, 2010
Published for Opposition
Tuesday, September 7, 2010
Abandoned Date
Monday, December 9, 2013
42 Conducting clinical trials; conducting clinical trials on the safety and effectiveness of apremilast; conducting clinical trials on the safety and effectiveness of a drug for Psoriasis, Rheumatoid Arthritis and Cancer; conducting clinical trials on the safety and effectiveness of a drug directed to Prostate-specific antigen
Dec 9, 2013
Abandonment Notice Mailed - No Use Statement Filed
Dec 9, 2013
Abandonment - No Use Statement Filed
Mar 29, 2013
Notice Of Approval Of Extension Request E-Mailed
Mar 28, 2013
Extension 5 Granted
Mar 22, 2013
Extension 5 Filed
Mar 22, 2013
Teas Extension Received
Oct 19, 2012
Notice Of Approval Of Extension Request E-Mailed
Oct 18, 2012
Extension 4 Granted
Oct 16, 2012
Extension 4 Filed
Oct 16, 2012
Teas Extension Received
Apr 18, 2012
Notice Of Approval Of Extension Request E-Mailed
Apr 17, 2012
Extension 3 Granted
Apr 12, 2012
Extension 3 Filed
Apr 12, 2012
Teas Extension Received
Sep 10, 2011
Notice Of Approval Of Extension Request E-Mailed
Sep 9, 2011
Extension 2 Granted
Sep 7, 2011
Extension 2 Filed
Sep 9, 2011
Case Assigned To Intent To Use Paralegal
Sep 7, 2011
Teas Extension Received
Mar 17, 2011
Notice Of Approval Of Extension Request E-Mailed
Mar 15, 2011
Extension 1 Granted
Mar 15, 2011
Extension 1 Filed
Mar 15, 2011
Teas Extension Received
Nov 2, 2010
Noa E-Mailed - Sou Required From Applicant
Sep 7, 2010
Official Gazette Publication Confirmation E-Mailed
Sep 7, 2010
Published For Opposition
Aug 2, 2010
Law Office Publication Review Completed
Aug 2, 2010
Assigned To Lie
Jul 19, 2010
Approved For Pub - Principal Register
Jul 12, 2010
Assigned To Examiner
Jun 14, 2010
New Application Office Supplied Data Entered In Tram
Jun 12, 2010
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
